VANDRIA Trademark

Trademark Overview


On Friday, August 27, 2021, a trademark application was filed for VANDRIA with the United States Patent and Trademark Office. The USPTO has given the VANDRIA trademark a serial number of 90905974. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Amazentis SA. The VANDRIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
vandria

General Information


Serial Number90905974
Word MarkVANDRIA
Filing DateFriday, August 27, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
Goods and ServicesResearch and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVANDRIA SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLAUSANNE 1015
CH

Party NameVANDRIA SA
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLAUSANNE 1015
CH

Party NameAmazentis SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEcublens 1024
CH

Trademark Events


Event DateEvent Description
Wednesday, January 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 31, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 6, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 2, 2022ASSIGNED TO EXAMINER
Monday, June 6, 2022SUSPENSION LETTER WRITTEN
Monday, June 6, 2022LETTER OF SUSPENSION E-MAILED
Friday, September 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 3, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 1, 2022ASSIGNED TO LIE
Friday, September 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 23, 2023SOU EXTENSION 1 FILED
Thursday, March 23, 2023SOU EXTENSION 1 GRANTED
Saturday, March 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 2 FILED
Monday, September 18, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU EXTENSION 3 FILED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024SOU EXTENSION 3 GRANTED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 4 GRANTED
Friday, October 25, 2024SOU EXTENSION 4 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED